MS Affects the Cover You Want Less Than You Think

Getting life insurance with multiple sclerosis is more achievable than most newly diagnosed people expect, and the reason is worth understanding before you fill anything in: life cover responds only to death. That is a far narrower promise than the products people usually reach for first, and it is why the answer to "can you get life insurance with MS?" is so often more encouraging than people have braced themselves for.

Multiple sclerosis is frightening partly because of what it threatens — mobility, work, independence, the shape of an ordinary week. But none of those is the thing a life insurance policy pays out on. A life policy pays when someone dies, and for most people with MS, most of the time, the condition is not one that dramatically shortens life. That gap, between what MS threatens and what life cover actually insures, is the whole reason life assurance is usually the most obtainable of the three main protection products, even though it is the one people assume will be hardest to get.

The products an MS diagnosis more often closes, or prices out, are critical illness cover and income protection — because those respond to disability and to being unable to work, which is precisely the ground MS occupies. This article is about the life decision specifically: how the disease course, the time since your diagnosis and any disability scoring drive what an underwriter offers, and why a rated or postponed answer from one insurer is not the market's final word.

The short answer: life cover is not the product MS usually closes

If you take one thing from this page, take this. There are three products people mean when they say "insurance" in the context of a diagnosis, and they behave completely differently when MS is on the record.

Life insurance pays a lump sum when you die. Critical illness cover pays a lump sum when you are diagnosed with one of a defined list of serious conditions at a defined severity. Income protection pays a monthly amount when illness or injury stops you working. MS lands hardest on the last two, because they are triggered by exactly the kind of disability the condition can cause. Life cover sits apart, because the only trigger is death — and MS is not, for most people, a rapidly life-shortening illness.

So when someone tells you they "couldn't get insured" after an MS diagnosis, it is worth asking which product they meant. Very often it was critical illness or income protection that was declined or heavily loaded, and the person reasonably assumed life cover would be the same or worse. In practice the life application is frequently the one that comes back on terms close to what an applicant without the diagnosis would have been offered.

Why life, critical illness and income protection diverge

The divergence is not an accident of pricing; it follows directly from what each policy insures. An underwriter pricing life cover is estimating the chance of death within the policy term. An underwriter pricing critical illness or income protection is estimating the chance of a qualifying diagnosis or of extended time off work. MS moves those two probabilities much more than it moves the first.

This is why the same person can hold a rated income protection policy, a declined critical illness application and a near-standard life policy all at once, and it is not a contradiction. Each product has assessed a different question. It also explains why it is worth being deliberate about which cover you actually need. If the point of the cover is to clear a mortgage or leave a lump sum for a family if you die, life insurance is the product that does that job — and it is the product MS interferes with least.

If you already hold protection through work or through your own company, the picture can be gentler again, because group schemes and some employer arrangements provide cover without individual medical underwriting up to a set limit. Where your cover runs through a limited company, though, be aware that a relevant life plan still underwrites the director's health individually, so the MS questions come back on that route.

What an underwriter actually asks about MS

An MS diagnosis does not produce a single automatic decision. It opens a short set of questions, and the answers place you on a spectrum rather than in a box. Expect to be asked about most of the following:

• The date of diagnosis. When MS was confirmed, and how long the condition has been followed.
• The disease course. Whether it is relapsing-remitting, secondary progressive or primary progressive.
• Relapse history. How many relapses you have had, how severe they were, and when the most recent one was.
• Current function and mobility. How MS affects daily life now, and whether you use any walking aids.
• Any disability score. A neurologist may have recorded a score such as the Expanded Disability Status Scale (EDSS), which underwriters recognise.
• Medication. Your current treatment, including any disease-modifying therapies.
• Work. Whether you are still working, and in what capacity.

None of these questions is a trap. They are the underwriter's way of turning a broad label — "MS" — into a specific risk it can price. The most useful thing you can do is answer them accurately and, where you can, have your neurologist's letters to hand, because a clear, documented history almost always produces a better outcome than a vague one.

Disease course, and why the label on your diagnosis matters

Multiple sclerosis is not one illness with one trajectory, and underwriters treat the recognised courses differently because they carry genuinely different outlooks.

Relapsing-remitting MS, the most common pattern at diagnosis, involves flare-ups followed by periods of partial or full recovery. Where relapses are infrequent, recovery between them is good and function is preserved, this is generally the course that produces the most favourable life terms. Secondary progressive MS, where a relapsing-remitting course has begun to accumulate steadier disability over time, tends to be read more cautiously. Primary progressive MS, which worsens gradually from the outset without distinct relapses, is assessed on its own terms again, with weight given to the rate of progression and current function.

The point is not that one label is "good" and another "bad". It is that a word like "MS" on its own tells an underwriter very little, and the course, the relapse pattern and the function behind it tell it almost everything. Two people who both simply say they "have MS" can, quite properly, receive very different decisions — which is also why a rejection or a loading aimed at someone else's history says nothing reliable about yours. For a plain-English description of the condition and its types, the NHS overview of multiple sclerosis is a good starting point.

Time since diagnosis, and why a recent one can mean "not yet"

Timing matters more than almost anything else. An underwriter is looking for an established pattern, and a diagnosis made only weeks or months ago often has not produced one yet. The course may still be unclear, the response to treatment unknown, and the first year unrepresentative of how the condition will actually behave.

Where the picture is genuinely unsettled, the outcome is frequently a postponement rather than a decline. This is an important distinction, and it is easy to misread in the moment. A postponement means the insurer wants to look again once there is more to see; it is a "not yet", and it usually comes with a rough idea of how long the insurer wants to wait. A longer, calmer history — several years, few relapses, stable function — commonly produces markedly better terms than an application filed in the anxious first months after a diagnosis.

If you are postponed, treat it the way you would any staged reassessment: note what the insurer said it wanted to see, keep your medical records in order, and go back when the interval has passed. The same discipline governs other conditions where the sensible move is to let the picture settle before applying again — the logic behind knowing when to reapply after treatment finishes is exactly the same, even though the condition is different.

Disability scoring, function and the law behind the questions

Where a neurologist has recorded a disability score, an underwriter will pay attention to it, because it converts "how is your MS?" into something consistent. Scales such as the EDSS capture mobility and function in a way insurers can compare, and a stable, low level of disability sustained over years is one of the stronger factors in your favour. What matters is not the existence of a score but what it shows about how the condition is actually affecting you.

There is a legal frame around all of this that is worth knowing. In England, Wales and Scotland, the Equality Act 2010 allows an insurer to take a disability into account only where it relies on information that is relevant to the risk and comes from a source it is reasonable to rely on. You are entitled to ask what information a decision was based on. Northern Ireland is not covered by the Equality Act 2010; there, disability discrimination in the provision of services is governed by the Disability Discrimination Act 1995 as amended, which contains its own equivalent provisions. The practical upshot is the same across the UK: a decision should rest on real, relevant medical evidence, not on the bare fact of the label — and you can ask to see the reasoning.

If the terms come back rated — matching the cover you actually need

Sometimes the answer is a loading rather than standard terms, and occasionally it is a decline from a particular insurer. Neither is the end of the road, because underwriting appetite for MS varies considerably from one insurer to the next. A single answer is one insurer's view of your risk, not the market's, and this is precisely the situation where an FCA-authorised broker earns their place: they know which insurers look more kindly on neurological conditions and can present your history — the letters, the scores, the stable years — in the way underwriters want to see it.

It is also worth being deliberate about the shape of the cover, not just the fact of it. If the purpose is to protect a repayment mortgage, a decreasing term policy that tracks the balance down is usually the efficient choice, and the way a risk is priced on a mortgage-linked policy can be gentler than on a large level sum — the same effect that lets family history cost less on a mortgage policy. Whatever the structure, check the term runs as long as the debt does, because it is genuinely common for the mortgage to run to 70 while the cover stops at 65, leaving an uninsured tail at exactly the age it matters most.

Remember, too, that MS is only one of the questions on the form. Your occupation is assessed on its own axis, so a physically demanding or hazardous job — the kind of work that can change the premium the way being a scaffolder changes the premium — is weighed separately from the health history. When you are ready to see real figures against your own situation, you can get life insurance quotes and ask a broker to run the MS case across more than one insurer rather than accepting the first answer. The wider set of health, history and occupation questions insurers use is gathered in the guide to getting cover with a history, a condition or a job.

Frequently asked questions

Can you get life insurance with multiple sclerosis?

Frequently, yes. Life cover responds only to death, and many people with MS have a life expectancy close to average, so terms are often better than expected. Critical illness cover and income protection are usually harder to obtain, because they respond to disability rather than to death, which is the ground MS more directly affects.

What will underwriters ask about?

The date of diagnosis, whether the course is relapsing-remitting, secondary progressive or primary progressive, how many relapses you have had and when, your current mobility and any disability scoring, your medication including any disease-modifying therapies, and whether you are still working. Clear neurologist's letters help the assessment considerably.

Does a recent diagnosis make it harder?

Often. Insurers look for an established pattern, so a very recent diagnosis with an unclear course can lead to a postponement while the picture settles. A longer history with few relapses and good function generally produces more favourable terms than an application filed in an unsettled first year.